Home Biosimilar Antibodies Immunology & Inflammation IL Receptor antibody Lusvertikimab (Anti-IL-7Ra / CD127) For research use only.
Not for use in humans.

Lusvertikimab (Anti-IL-7Ra / CD127)

Synonyms: OSE-127

Lusvertikimab (Anti-IL-7Ra / CD127) is a humanized monoclonal antibody targeting IL7R. It has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research. MW :145.64 KD.

Lusvertikimab (Anti-IL-7Ra / CD127)

Purity & Quality Control

≥99

Choose Selective IL Receptor Inhibitors

Biological Activity

Description Lusvertikimab (Anti-IL-7Ra / CD127) is a humanized monoclonal antibody targeting IL7R. It has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research. MW :145.64 KD.

Product Details

CAS No. 2375835-91-7
Molecular Weight 145.64
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lusvertikimab (Anti-IL-7Ra / CD127) | Lusvertikimab (Anti-IL-7Ra / CD127) supplier | purchase Lusvertikimab (Anti-IL-7Ra / CD127) | Lusvertikimab (Anti-IL-7Ra / CD127) cost | Lusvertikimab (Anti-IL-7Ra / CD127) manufacturer | order Lusvertikimab (Anti-IL-7Ra / CD127) | Lusvertikimab (Anti-IL-7Ra / CD127) distributor